Kin-Hung Peony Yu
About Kin-Hung Peony Yu
Professional Title and Current Position
Kin-Hung Peony Yu serves as the Chief Medical Officer at Apollomics, a position she has held since 2021. In her role, she focuses on leading the company's clinical regulatory strategy and executing clinical programs for innovative biopharmaceuticals.
Experience in Pharmaceutical Leadership
With over 25 years of experience in pharmaceutical leadership, Kin-Hung Peony Yu has established herself in the realms of patient care and drug development. Her extensive career includes significant roles at various biopharmaceutical companies. Prior to joining Apollomics, she worked at FibroGen, Inc. as a vice president. Her previous leadership roles also include positions at Anesiva, Inc., ALZA Corporation (a Johnson & Johnson subsidiary), Pain Therapeutics, Inc., and Elan Corporation plc.
Education and Medical Training
Kin-Hung Peony Yu earned her M.D. degree from the University of California, Davis School of Medicine. She completed her residency training at Stanford University School of Medicine. In addition, she holds a medical license registered in California, underscoring her qualifications and medical expertise.
Clinical Research and Publications
Throughout her career, Kin-Hung Peony Yu has contributed to clinical research and has been involved in the development of several key clinical programs. She has authored or co-authored 12 peer-reviewed publications, sharing her insights and findings with the medical and scientific community.
Independent Director Roles
Beyond her work at Apollomics, Kin-Hung Peony Yu serves as an independent nonexecutive director at STAAR Surgical Company. Her involvement in this role highlights her ongoing commitment to advancing healthcare through diverse leadership positions.